Skip to content

Author

Yuji Hataya

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Case report Open access Jul 2026

Thyroid eye disease with teprotumumab-related hyperglycemia associated with increased growth hormone secretion

Abstract Teprotumumab, an insulin-like growth factor-1 (IGF-1) receptor antibody, has been approved for thyroid eye disease (TED) treatment. However, teprotumumab is associated with adverse events such as hyperglycemia, and the underlying mechanisms of teprotumumab-related hyperglycemia remain unclear. We report a case...

Ken Sugawa, Yuji Hataya, Kimiaki Murabe et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.